The study team will conduct a cluster randomized control trial in 10 NYU primary care practices to assess the effectiveness and implementation of the multicomponent intervention on medication adherence and blood pressure control for patients who are non-adherent to antihypertensive medications.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
1,842
The intervention consist of four components: 1) patients with hypertension will be automatically screened for low medication adherence using linked EHR-pharmacy data at the time of a PCP encounter; 2) MAs will deliver a validated, rapid, survey of common causes of non-adherence; 3) MAs and/or RNs will address barriers to adherence tailored to survey response, including delivery of brief health coaching based on motivational interviewing; and 4) PCPs will address specific barriers to adherence based on survey response.
NYU Langone Health
New York, New York, United States
Average Number of Days Covered (PDC) as a Measure of Medication Adherence
The percentage of days covered (PDC) is used to estimate medication adherence by looking at the percentage of days in which a person has access to the medication, over a given period of interest
Time frame: Month 12
Average Number of Days Covered (PDC) as a Measure of Medication Adherence
The percentage of days covered (PDC) is used to estimate medication adherence by looking at the percentage of days in which a person has access to the medication, over a given period of interest
Time frame: Month 18
Mean Systolic Blood Pressure
Time frame: Month 12
Mean Systolic Blood Pressure
Time frame: Month 18
Mean Diastolic Blood Pressure
Time frame: Month 12
Mean Diastolic Blood Pressure
Time frame: Month 18
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.